Loading…
Lobbying Income
$2.1M
Filings
59
Unique Clients
4
Active Period
2022–2026
Registrant-reported income from clients on LDA filings
Largest clients by registrant-reported income
Government entities explicitly identified as targets in LDA filings
Most frequently reported lobbying issues
Bill numbers found in source-reported LDA specific issue text; broad topic matches are excluded
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
2025 · second_quarter · Client: CENCORA, INC.
HR 1: The One Big Beautiful Bill Act Issues related to the tax status of Puerto Rico and the U.S. Virgin Islands
Client expense: — · Firm income: $30,000
Matched citations: HR 1
Pharmacy Benefit Manager Reform Act
2024 · fourth_quarter · Client: COHERUS BIOSCIENCES, INC
Issues related to drug shortages and the pharmaceutical supply chain S.1339 The Pharmacy Benefit Manger Reform Act Issues related to coverage of Biosimilars within Medicare Part D Issues related to the strategic national stockpile Issues related to the procurement of the medicine "Udenyca" for the treatment of acute radiation exposure
Client expense: — · Firm income: $45,000
Matched citations: S.1339
Pharmacy Benefit Manager Reform Act
2024 · fourth_quarter · Client: COHERUS BIOSCIENCES, INC
Issues related to reform of pharmacy benefit managers Issues related to drug shortages and the pharmaceutical supply chainS. S. 1339 The Pharmacy Benefit Manger Reform Act Issues related to coverage of biosimilars within Medicare Part D Issues related to the strategic national stockpile Issues related to the procurement of the medicine "Udenyca" for the treatment of acute radiation exposure
Client expense: — · Firm income: $45,000
Matched citations: S. 1339
Modernizing and Ensuring PBM Accountability Act
2024 · fourth_quarter · Client: CENCORA, INC.
Drug shortage policy and issues related to drug shortages and the medical supply chain S.2973-Modernizing and Ensuring PBM Accountability Act
Client expense: — · Firm income: $30,000
Matched citations: S.2973
Modernizing and Ensuring PBM Accountability Act
2024 · fourth_quarter · Client: CENCORA, INC.
Drug shortage policy and issues related to drug shortages and the medical supply chain. S.2973-Modernizing and Ensuring PBM Accountability Act
Client expense: — · Firm income: $30,000
Matched citations: S.2973
Modernizing and Ensuring PBM Accountability Act
2024 · third_quarter · Client: CENCORA, INC.
Drug shortage policy and issues related to drug shortages and the medical supply chain S.2973-Modernizing and Ensuring PBM Accountability Act Issues related to the Change Healthcare Cyber Attack
Client expense: — · Firm income: $30,000
Matched citations: S.2973
Modernizing and Ensuring PBM Accountability Act
2024 · third_quarter · Client: CENCORA, INC.
Drug shortage policy and issues related to drug shortages and the medical supply chain. S.2973-Modernizing and Ensuring PBM Accountability Act Issues related to the Change Healthcare Cyber Attack
Client expense: — · Firm income: $30,000
Matched citations: S.2973
Pharmacy Benefit Manager Reform Act
2024 · third_quarter · Client: COHERUS BIOSCIENCES, INC
Issues related to drug shortages and the pharmaceutical supply chain S.1339 The Pharmacy Benefit Manger Reform Act Issues related to coverage of Biosimilars within Medicare Part D
Client expense: — · Firm income: $45,000
Matched citations: S.1339
Pharmacy Benefit Manager Reform Act
2024 · third_quarter · Client: COHERUS BIOSCIENCES, INC
Issues related to reform of pharmacy benefit managers Issues related to drug shortages and the pharmaceutical supply chainS. S. 1339 The Pharmacy Benefit Manger Reform Act Issues related to coverage of Biosimilars within Medicare Part D
Client expense: — · Firm income: $45,000
Matched citations: S. 1339
Modernizing and Ensuring PBM Accountability Act
2024 · second_quarter · Client: CENCORA, INC.
Drug shortage policy, S.2973-Modernizing and Ensuring PBM Accountability Act Issues related to the Change Healthcare Cyber Attack
Client expense: — · Firm income: $30,000
Matched citations: S.2973
Modernizing and Ensuring PBM Accountability Act
2024 · second_quarter · Client: CENCORA, INC.
Drug shortage policy, S.2973-Modernizing and Ensuring PBM Accountability Act Issues related to the Change Healthcare Cyber Attack
Client expense: — · Firm income: $30,000
Matched citations: S.2973
Pharmacy Benefit Manager Reform Act
2024 · second_quarter · Client: COHERUS BIOSCIENCES, INC
Issues related to FDA Inspections Issues related to drug shortages and the pharmaceutical supply chain S.1339 The Pharmacy Benefit Manger Reform Act Issues related to coverage of Biosimilars within Medicare Part D
Client expense: — · Firm income: $45,000
Matched citations: S.1339
Pharmacy Benefit Manager Reform Act
2024 · second_quarter · Client: COHERUS BIOSCIENCES, INC
Issues related to FDA Inspections Issues related to reform of pharmacy benefit managers Issues related to drug shortages and the pharmaceutical supply chainS. S. 1339 The Pharmacy Benefit Manger Reform Act Issues related to coverage of Biosimilars within Medicare Part D
Client expense: — · Firm income: $45,000
Matched citations: S. 1339
Modernizing and Ensuring PBM Accountability Act
2024 · first_quarter · Client: CENCORA, INC.
Drug shortage policy, S.2973-Modernizing and Ensuring PBM Accountability Act
Client expense: — · Firm income: $10,000
Matched citations: S.2973
Modernizing and Ensuring PBM Accountability Act
2024 · first_quarter · Client: CENCORA, INC.
Drug shortage policy, S.2973-Modernizing and Ensuring PBM Accountability Act
Client expense: — · Firm income: $10,000
Matched citations: S.2973
Pharmacy Benefit Manager Reform Act
2024 · first_quarter · Client: COHERUS BIOSCIENCES, INC
S. 2082 The American Made Pharmaceuticals Act Drug Pricing Reform Issues related to FDA Inspections Issues related to reform of pharmacy benefit managers Issues related to drug shortages and the pharmaceutical supply chainS. S. 1339 The Pharmacy Benefit Manger Reform Act Issues related to coverage of Biosimilars within Medicare Part D
Client expense: — · Firm income: $45,000
Matched citations: S. 1339
Pharmacy Benefit Manager Reform Act
2024 · first_quarter · Client: COHERUS BIOSCIENCES, INC
S. 2082 The American Made Pharmaceuticals Act Drug Pricing Reform Issues related to FDA Inspections Issues related to drug shortages and the pharmaceutical supply chain S.1339 The Pharmacy Benefit Manger Reform Act Issues related to coverage of Biosimilars within Medicare Part D
Client expense: — · Firm income: $45,000
Matched citations: S.1339
Ensuring Justice for Victims of Terrorism Act
2024 · first_quarter · Client: COHERUS BIOSCIENCES, INC
S. 2082 The American Made Pharmaceuticals Act Drug Pricing Reform Issues related to FDA Inspections Issues related to reform of pharmacy benefit managers Issues related to drug shortages and the pharmaceutical supply chainS. S. 1339 The Pharmacy Benefit Manger Reform Act Issues related to coverage of Biosimilars within Medicare Part D
Client expense: — · Firm income: $45,000
Matched citations: S. 2082
Ensuring Justice for Victims of Terrorism Act
2024 · first_quarter · Client: COHERUS BIOSCIENCES, INC
S. 2082 The American Made Pharmaceuticals Act Drug Pricing Reform Issues related to FDA Inspections Issues related to drug shortages and the pharmaceutical supply chain S.1339 The Pharmacy Benefit Manger Reform Act Issues related to coverage of Biosimilars within Medicare Part D
Client expense: — · Firm income: $45,000
Matched citations: S. 2082
Pharmacy Benefit Manager Reform Act
2023 · fourth_quarter · Client: COHERUS BIOSCIENCES, INC
S. 2082 The American Made Pharmaceuticals Act Drug Pricing Reform Issues related to FDA Inspections Issues related to reform of pharmacy benefit managers Issues related to drug shortages and the pharmaceutical supply chainS. S. 1339 The Pharmacy Benefit Manger Reform Act Issues related to coverage of Biosimilars within Medicare Part D
Client expense: — · Firm income: $45,000
Matched citations: S. 1339
Pharmacy Benefit Manager Reform Act
2023 · fourth_quarter · Client: COHERUS BIOSCIENCES, INC
S. 2082 The American Made Pharmaceuticals Act Drug Pricing Reform Issues related to FDA Inspections Issues related to drug shortages and the pharmaceutical supply chain S.1339 The Pharmacy Benefit Manger Reform Act Issues related to coverage of Biosimilars within Medicare Part D
Client expense: — · Firm income: $45,000
Matched citations: S.1339
Ensuring Justice for Victims of Terrorism Act
2023 · fourth_quarter · Client: COHERUS BIOSCIENCES, INC
S. 2082 The American Made Pharmaceuticals Act Drug Pricing Reform Issues related to FDA Inspections Issues related to reform of pharmacy benefit managers Issues related to drug shortages and the pharmaceutical supply chainS. S. 1339 The Pharmacy Benefit Manger Reform Act Issues related to coverage of Biosimilars within Medicare Part D
Client expense: — · Firm income: $45,000
Matched citations: S. 2082
Ensuring Justice for Victims of Terrorism Act
2023 · fourth_quarter · Client: COHERUS BIOSCIENCES, INC
S. 2082 The American Made Pharmaceuticals Act Drug Pricing Reform Issues related to FDA Inspections Issues related to drug shortages and the pharmaceutical supply chain S.1339 The Pharmacy Benefit Manger Reform Act Issues related to coverage of Biosimilars within Medicare Part D
Client expense: — · Firm income: $45,000
Matched citations: S. 2082
Ensuring Justice for Victims of Terrorism Act
2023 · third_quarter · Client: COHERUS BIOSCIENCES, INC
S. 2082 The American Made Pharmaceuticals Act Drug Pricing Reform Issues related to reform of Pharmacy Benefit Mangers Issues related to FDA Inspections Issues related to drug shortages and the pharmaceutical supply chain
Client expense: — · Firm income: $45,000
Matched citations: S. 2082
Ensuring Justice for Victims of Terrorism Act
2023 · third_quarter · Client: COHERUS BIOSCIENCES, INC
S. 2082 The American Made Pharmaceuticals Act Drug Pricing Reform Issues related to FDA Inspections Issues related to reform of pharmacy benefit managers Issues related to drug shortages and the pharmaceutical supply chain
Client expense: — · Firm income: $45,000
Matched citations: S. 2082
Source: Senate LDA